CIC
Chilton Investment Company Portfolio holdings
AUM
$4.5B
1-Year Return
26.04%
This Quarter Return
+13.05%
1 Year Return
+26.04%
3 Year Return
+78.02%
5 Year Return
+132.72%
10 Year Return
+346.15%
AUM
$3.4B
AUM Growth
+$258M
(+8.2%)
Cap. Flow
-$127M
Cap. Flow
% of AUM
-3.74%
Top 10 Holdings %
Top 10 Hldgs %
58.21%
Holding
184
New
18
Increased
48
Reduced
73
Closed
14
Top Buys
| 1 |
Arthur J. Gallagher & Co
AJG
|
$90.1M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$44.9M |
| 3 |
Morgan Stanley
MS
|
$37.3M |
| 4 |
IBM
IBM
|
$15.1M |
| 5 |
PepsiCo
PEP
|
$11.6M |
Top Sells
| 1 |
Aon
AON
|
$53.3M |
| 2 |
Apple
AAPL
|
$51.3M |
| 3 |
Hershey
HSY
|
$47.1M |
| 4 |
Thermo Fisher Scientific
TMO
|
$26.7M |
| 5 |
Home Depot
HD
|
$24.7M |
Sector Composition
| 1 | Industrials | 23.77% |
| 2 | Financials | 17.78% |
| 3 | Technology | 13.67% |
| 4 | Consumer Staples | 13.07% |
| 5 | Consumer Discretionary | 11.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Vanguard FTSE Developed Markets ETF
VEA
$170B
| $263K | 0.01% |
5,483
| – | – |
|
152
Vistra
VST
$64.3B
| $261K | 0.01% |
+6,787
| New | +$261K |
|
153
Starbucks
SBUX
$98.9B
| $261K | 0.01% |
2,720
| – | – |
|
154
Pool Corp
POOL
$11.8B
| $260K | 0.01% |
653
-8,444
| -93% | -$3.37M |
|
155
Labcorp
LH
$22.9B
| $248K | 0.01% |
1,092
| – | – |
|
156
iShares MSCI EAFE ETF
EFA
$65.9B
| $247K | 0.01% |
3,281
| – | – |
|
157
Reliance Steel & Aluminium
RS
$15.5B
| $247K | 0.01% |
883
| – | – |
|
158
Golub Capital BDC
GBDC
$3.94B
| $244K | 0.01% |
+16,166
| New | +$244K |
|
159
Adobe
ADBE
$146B
| $239K | 0.01% |
400
| – | – |
|
160
Parker-Hannifin
PH
$95.9B
| $233K | 0.01% |
+505
| New | +$233K |
|
161
Novartis
NVS
$249B
| $232K | 0.01% |
2,300
-61
| -3% | -$6.16K |
|
162
Five Below
FIVE
$8.43B
| $230K | 0.01% |
+1,079
| New | +$230K |
|
163
iShares Core S&P 500 ETF
IVV
$666B
| $214K | 0.01% |
+448
| New | +$214K |
|
164
Atkore
ATKR
$1.96B
| $212K | 0.01% |
1,322
-78
| -6% | -$12.5K |
|
165
Brown-Forman Class B
BF.B
$13.3B
| $211K | 0.01% |
+3,703
| New | +$211K |
|
166
Chubb
CB
$112B
| $211K | 0.01% |
+935
| New | +$211K |
|
167
Indivior
INDV
$3.09B
| $204K | 0.01% |
+17,230
| New | +$204K |
|
168
Wells Fargo
WFC
$262B
| $204K | 0.01% |
+4,148
| New | +$204K |
|
169
MaxCyte
MXCT
$145M
| $103K | ﹤0.01% |
21,933
| – | – |
|
|
PROF
170
Profound Medical
PROF
$133M
| $84.9K | ﹤0.01% |
+10,000
| New | +$84.9K |
|
171
Churchill Downs
CHDN
$7.15B
| – | – |
-19,434
| Closed | -$2.26M |
|
172
CrowdStrike
CRWD
$104B
| – | – |
-5,192
| Closed | -$869K |
|
173
Cisco
CSCO
$269B
| – | – |
-4,577
| Closed | -$246K |
|
174
CVS Health
CVS
$93.5B
| – | – |
-20,496
| Closed | -$1.43M |
|
175
American Airlines Group
AAL
$8.49B
| – | – |
-13,819
| Closed | -$177K |
|